Hurley Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$317K Sell
1,247
-1
-0.1% -$233 0.16% 77
2026
Q1
$305K Buy
1,248
+26
+2% +$6.06K 0.16% 70
2025
Q4
$253K Buy
1,222
+95
+8% +$18.8K 0.14% 70
2025
Q3
$209K Buy
1,127
+7
+0.6% +$1.2K 0.12% 88
2025
Q2
$171K Buy
1,120
+2
+0.2% +$307 0.12% 79
2025
Q1
$185K Sell
1,118
-4
-0.4% -$626 0.14% 84
2024
Q4
$164K Buy
+1,122
New +$174K 0.13% 76

Other funds holding JNJ

Hurley Capital's JNJ Position: Q2 2026 in Review

Hurley Capital reduced its Johnson & Johnson (JNJ) stake by 0.08% in Q2 2026, selling an estimated $233 and leaving 1,247 shares worth $317K. The position accounts for 0.16% of the portfolio, ranked #77.

Hurley Capital first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,686 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Hurley Capital held 1,247 shares of Johnson & Johnson worth $317K as of Q2 2026.
  • Hurley Capital sold 1 Johnson & Johnson share in Q2 2026, an estimated $233.
  • Johnson & Johnson made up 0.16% of Hurley Capital's portfolio in Q2 2026, its #77 holding.
  • Hurley Capital first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,686 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Hurley Capital's 13F filing for Q2 2026, filed 10 Aug 2026.